The global Corticosteroid Injections for Joint Pain market was valued at US$ 2145 million in 2023 and is anticipated to reach US$ 3244 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030.

Corticosteroid Injections for Joint Pain Market

Corticosteroid Injections products used for Joint Pain.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Corticosteroid Injections for Joint Pain, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Corticosteroid Injections for Joint Pain.

Report Scope

The Corticosteroid Injections for Joint Pain market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Corticosteroid Injections for Joint Pain market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Corticosteroid Injections for Joint Pain manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Corticosteroid Injections for Joint Pain Market Report

Report Metric	Details
Report Name	Corticosteroid Injections for Joint Pain Market
Accounted market size in 2023	US$ 2145 million
Forecasted market size in 2030	US$ 3244 million
CAGR	6.1%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Knee & Ankle Hip Joint Shoulder & Elbow Facet Joints of the Spine Others
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Allergan, Pfizer, Sanofi, Anika Therapeutics, Ferring, Bioventus, Flexion Therapeutics, Zimmer Biomet, SEIKAGAKU, Chugai Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Corticosteroid Injections for Joint Pain manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Corticosteroid Injections for Joint Pain in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Corticosteroid Injections for Joint Pain Market growing?

Ans: The Corticosteroid Injections for Joint Pain Market witnessing a CAGR of 6.1% during the forecast period 2024-2030.

What is the Corticosteroid Injections for Joint Pain Market size in 2030?

Ans: The Corticosteroid Injections for Joint Pain Market size in 2030 will be US$ 3244 million.

Who are the main players in the Corticosteroid Injections for Joint Pain Market report?

Ans: The main players in the Corticosteroid Injections for Joint Pain Market are Allergan, Pfizer, Sanofi, Anika Therapeutics, Ferring, Bioventus, Flexion Therapeutics, Zimmer Biomet, SEIKAGAKU, Chugai Pharma

What are the Application segmentation covered in the Corticosteroid Injections for Joint Pain Market report?

Ans: The Applications covered in the Corticosteroid Injections for Joint Pain Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Corticosteroid Injections for Joint Pain Market report?

Ans: The Types covered in the Corticosteroid Injections for Joint Pain Market report are Knee & Ankle, Hip Joint, Shoulder & Elbow, Facet Joints of the Spine, Others

1 Corticosteroid Injections for Joint Pain Market Overview

1.1 Product Overview and Scope of Corticosteroid Injections for Joint Pain

1.2 Corticosteroid Injections for Joint Pain Segment by Type

1.2.1 Global Corticosteroid Injections for Joint Pain Market Value Comparison by Type (2024-2030)

1.2.2 Knee & Ankle

1.2.3 Hip Joint

1.2.4 Shoulder & Elbow

1.2.5 Facet Joints of the Spine

1.2.6 Others

1.3 Corticosteroid Injections for Joint Pain Segment by Application

1.3.1 Global Corticosteroid Injections for Joint Pain Market Value by Application: (2024-2030)

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Global Corticosteroid Injections for Joint Pain Market Size Estimates and Forecasts

1.4.1 Global Corticosteroid Injections for Joint Pain Revenue 2019-2030

1.4.2 Global Corticosteroid Injections for Joint Pain Sales 2019-2030

1.4.3 Global Corticosteroid Injections for Joint Pain Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Corticosteroid Injections for Joint Pain Market Competition by Manufacturers

2.1 Global Corticosteroid Injections for Joint Pain Sales Market Share by Manufacturers (2019-2024)

2.2 Global Corticosteroid Injections for Joint Pain Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Corticosteroid Injections for Joint Pain Average Price by Manufacturers (2019-2024)

2.4 Global Corticosteroid Injections for Joint Pain Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Corticosteroid Injections for Joint Pain, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Corticosteroid Injections for Joint Pain, Product Type & Application

2.7 Corticosteroid Injections for Joint Pain Market Competitive Situation and Trends

2.7.1 Corticosteroid Injections for Joint Pain Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Corticosteroid Injections for Joint Pain Players Market Share by Revenue

2.7.3 Global Corticosteroid Injections for Joint Pain Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Corticosteroid Injections for Joint Pain Retrospective Market Scenario by Region

3.1 Global Corticosteroid Injections for Joint Pain Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Corticosteroid Injections for Joint Pain Global Corticosteroid Injections for Joint Pain Sales by Region: 2019-2030

3.2.1 Global Corticosteroid Injections for Joint Pain Sales by Region: 2019-2024

3.2.2 Global Corticosteroid Injections for Joint Pain Sales by Region: 2025-2030

3.3 Global Corticosteroid Injections for Joint Pain Global Corticosteroid Injections for Joint Pain Revenue by Region: 2019-2030

3.3.1 Global Corticosteroid Injections for Joint Pain Revenue by Region: 2019-2024

3.3.2 Global Corticosteroid Injections for Joint Pain Revenue by Region: 2025-2030

3.4 North America Corticosteroid Injections for Joint Pain Market Facts & Figures by Country

3.4.1 North America Corticosteroid Injections for Joint Pain Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Corticosteroid Injections for Joint Pain Sales by Country (2019-2030)

3.4.3 North America Corticosteroid Injections for Joint Pain Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Corticosteroid Injections for Joint Pain Market Facts & Figures by Country

3.5.1 Europe Corticosteroid Injections for Joint Pain Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Corticosteroid Injections for Joint Pain Sales by Country (2019-2030)

3.5.3 Europe Corticosteroid Injections for Joint Pain Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Corticosteroid Injections for Joint Pain Market Facts & Figures by Country

3.6.1 Asia Pacific Corticosteroid Injections for Joint Pain Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Corticosteroid Injections for Joint Pain Sales by Country (2019-2030)

3.6.3 Asia Pacific Corticosteroid Injections for Joint Pain Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Corticosteroid Injections for Joint Pain Market Facts & Figures by Country

3.7.1 Latin America Corticosteroid Injections for Joint Pain Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Corticosteroid Injections for Joint Pain Sales by Country (2019-2030)

3.7.3 Latin America Corticosteroid Injections for Joint Pain Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Corticosteroid Injections for Joint Pain Market Facts & Figures by Country

3.8.1 Middle East and Africa Corticosteroid Injections for Joint Pain Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Corticosteroid Injections for Joint Pain Sales by Country (2019-2030)

3.8.3 Middle East and Africa Corticosteroid Injections for Joint Pain Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Corticosteroid Injections for Joint Pain Sales by Type (2019-2030)

4.1.1 Global Corticosteroid Injections for Joint Pain Sales by Type (2019-2024)

4.1.2 Global Corticosteroid Injections for Joint Pain Sales by Type (2025-2030)

4.1.3 Global Corticosteroid Injections for Joint Pain Sales Market Share by Type (2019-2030)

4.2 Global Corticosteroid Injections for Joint Pain Revenue by Type (2019-2030)

4.2.1 Global Corticosteroid Injections for Joint Pain Revenue by Type (2019-2024)

4.2.2 Global Corticosteroid Injections for Joint Pain Revenue by Type (2025-2030)

4.2.3 Global Corticosteroid Injections for Joint Pain Revenue Market Share by Type (2019-2030)

4.3 Global Corticosteroid Injections for Joint Pain Price by Type (2019-2030)

5 Segment by Application

5.1 Global Corticosteroid Injections for Joint Pain Sales by Application (2019-2030)

5.1.1 Global Corticosteroid Injections for Joint Pain Sales by Application (2019-2024)

5.1.2 Global Corticosteroid Injections for Joint Pain Sales by Application (2025-2030)

5.1.3 Global Corticosteroid Injections for Joint Pain Sales Market Share by Application (2019-2030)

5.2 Global Corticosteroid Injections for Joint Pain Revenue by Application (2019-2030)

5.2.1 Global Corticosteroid Injections for Joint Pain Revenue by Application (2019-2024)

5.2.2 Global Corticosteroid Injections for Joint Pain Revenue by Application (2025-2030)

5.2.3 Global Corticosteroid Injections for Joint Pain Revenue Market Share by Application (2019-2030)

5.3 Global Corticosteroid Injections for Joint Pain Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Allergan

6.1.1 Allergan Corporation Information

6.1.2 Allergan Description and Business Overview

6.1.3 Allergan Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Allergan Corticosteroid Injections for Joint Pain Product Portfolio

6.1.5 Allergan Recent Developments/Updates

6.2 Pfizer

6.2.1 Pfizer Corporation Information

6.2.2 Pfizer Description and Business Overview

6.2.3 Pfizer Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Pfizer Corticosteroid Injections for Joint Pain Product Portfolio

6.2.5 Pfizer Recent Developments/Updates

6.3 Sanofi

6.3.1 Sanofi Corporation Information

6.3.2 Sanofi Description and Business Overview

6.3.3 Sanofi Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Sanofi Corticosteroid Injections for Joint Pain Product Portfolio

6.3.5 Sanofi Recent Developments/Updates

6.4 Anika Therapeutics

6.4.1 Anika Therapeutics Corporation Information

6.4.2 Anika Therapeutics Description and Business Overview

6.4.3 Anika Therapeutics Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Anika Therapeutics Corticosteroid Injections for Joint Pain Product Portfolio

6.4.5 Anika Therapeutics Recent Developments/Updates

6.5 Ferring

6.5.1 Ferring Corporation Information

6.5.2 Ferring Description and Business Overview

6.5.3 Ferring Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Ferring Corticosteroid Injections for Joint Pain Product Portfolio

6.5.5 Ferring Recent Developments/Updates

6.6 Bioventus

6.6.1 Bioventus Corporation Information

6.6.2 Bioventus Description and Business Overview

6.6.3 Bioventus Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Bioventus Corticosteroid Injections for Joint Pain Product Portfolio

6.6.5 Bioventus Recent Developments/Updates

6.7 Flexion Therapeutics

6.6.1 Flexion Therapeutics Corporation Information

6.6.2 Flexion Therapeutics Description and Business Overview

6.6.3 Flexion Therapeutics Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Flexion Therapeutics Corticosteroid Injections for Joint Pain Product Portfolio

6.7.5 Flexion Therapeutics Recent Developments/Updates

6.8 Zimmer Biomet

6.8.1 Zimmer Biomet Corporation Information

6.8.2 Zimmer Biomet Description and Business Overview

6.8.3 Zimmer Biomet Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Zimmer Biomet Corticosteroid Injections for Joint Pain Product Portfolio

6.8.5 Zimmer Biomet Recent Developments/Updates

6.9 SEIKAGAKU

6.9.1 SEIKAGAKU Corporation Information

6.9.2 SEIKAGAKU Description and Business Overview

6.9.3 SEIKAGAKU Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2019-2024)

6.9.4 SEIKAGAKU Corticosteroid Injections for Joint Pain Product Portfolio

6.9.5 SEIKAGAKU Recent Developments/Updates

6.10 Chugai Pharma

6.10.1 Chugai Pharma Corporation Information

6.10.2 Chugai Pharma Description and Business Overview

6.10.3 Chugai Pharma Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Chugai Pharma Corticosteroid Injections for Joint Pain Product Portfolio

6.10.5 Chugai Pharma Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Corticosteroid Injections for Joint Pain Industry Chain Analysis

7.2 Corticosteroid Injections for Joint Pain Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Corticosteroid Injections for Joint Pain Production Mode & Process

7.4 Corticosteroid Injections for Joint Pain Sales and Marketing

7.4.1 Corticosteroid Injections for Joint Pain Sales Channels

7.4.2 Corticosteroid Injections for Joint Pain Distributors

7.5 Corticosteroid Injections for Joint Pain Customers

8 Corticosteroid Injections for Joint Pain Market Dynamics

8.1 Corticosteroid Injections for Joint Pain Industry Trends

8.2 Corticosteroid Injections for Joint Pain Market Drivers

8.3 Corticosteroid Injections for Joint Pain Market Challenges

8.4 Corticosteroid Injections for Joint Pain Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Corticosteroid Injections for Joint Pain Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Corticosteroid Injections for Joint Pain Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Corticosteroid Injections for Joint Pain Market Competitive Situation by Manufacturers in 2023

Table 4. Global Corticosteroid Injections for Joint Pain Sales (Units) of Key Manufacturers (2019-2024)

Table 5. Global Corticosteroid Injections for Joint Pain Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Corticosteroid Injections for Joint Pain Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Corticosteroid Injections for Joint Pain Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Corticosteroid Injections for Joint Pain Average Price (USD/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Corticosteroid Injections for Joint Pain, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Corticosteroid Injections for Joint Pain, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Corticosteroid Injections for Joint Pain, Product Type & Application

Table 12. Global Key Manufacturers of Corticosteroid Injections for Joint Pain, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Corticosteroid Injections for Joint Pain by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Corticosteroid Injections for Joint Pain as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Corticosteroid Injections for Joint Pain Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Corticosteroid Injections for Joint Pain Sales by Region (2019-2024) & (Units)

Table 18. Global Corticosteroid Injections for Joint Pain Sales Market Share by Region (2019-2024)

Table 19. Global Corticosteroid Injections for Joint Pain Sales by Region (2025-2030) & (Units)

Table 20. Global Corticosteroid Injections for Joint Pain Sales Market Share by Region (2025-2030)

Table 21. Global Corticosteroid Injections for Joint Pain Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Region (2019-2024)

Table 23. Global Corticosteroid Injections for Joint Pain Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Region (2025-2030)

Table 25. North America Corticosteroid Injections for Joint Pain Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Corticosteroid Injections for Joint Pain Sales by Country (2019-2024) & (Units)

Table 27. North America Corticosteroid Injections for Joint Pain Sales by Country (2025-2030) & (Units)

Table 28. North America Corticosteroid Injections for Joint Pain Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Corticosteroid Injections for Joint Pain Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Corticosteroid Injections for Joint Pain Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Corticosteroid Injections for Joint Pain Sales by Country (2019-2024) & (Units)

Table 32. Europe Corticosteroid Injections for Joint Pain Sales by Country (2025-2030) & (Units)

Table 33. Europe Corticosteroid Injections for Joint Pain Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Corticosteroid Injections for Joint Pain Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Corticosteroid Injections for Joint Pain Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Corticosteroid Injections for Joint Pain Sales by Region (2019-2024) & (Units)

Table 37. Asia Pacific Corticosteroid Injections for Joint Pain Sales by Region (2025-2030) & (Units)

Table 38. Asia Pacific Corticosteroid Injections for Joint Pain Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Corticosteroid Injections for Joint Pain Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Corticosteroid Injections for Joint Pain Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Corticosteroid Injections for Joint Pain Sales by Country (2019-2024) & (Units)

Table 42. Latin America Corticosteroid Injections for Joint Pain Sales by Country (2025-2030) & (Units)

Table 43. Latin America Corticosteroid Injections for Joint Pain Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Corticosteroid Injections for Joint Pain Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Corticosteroid Injections for Joint Pain Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Corticosteroid Injections for Joint Pain Sales by Country (2019-2024) & (Units)

Table 47. Middle East & Africa Corticosteroid Injections for Joint Pain Sales by Country (2025-2030) & (Units)

Table 48. Middle East & Africa Corticosteroid Injections for Joint Pain Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Corticosteroid Injections for Joint Pain Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Corticosteroid Injections for Joint Pain Sales (Units) by Type (2019-2024)

Table 51. Global Corticosteroid Injections for Joint Pain Sales (Units) by Type (2025-2030)

Table 52. Global Corticosteroid Injections for Joint Pain Sales Market Share by Type (2019-2024)

Table 53. Global Corticosteroid Injections for Joint Pain Sales Market Share by Type (2025-2030)

Table 54. Global Corticosteroid Injections for Joint Pain Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Corticosteroid Injections for Joint Pain Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Type (2019-2024)

Table 57. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Type (2025-2030)

Table 58. Global Corticosteroid Injections for Joint Pain Price (USD/Unit) by Type (2019-2024)

Table 59. Global Corticosteroid Injections for Joint Pain Price (USD/Unit) by Type (2025-2030)

Table 60. Global Corticosteroid Injections for Joint Pain Sales (Units) by Application (2019-2024)

Table 61. Global Corticosteroid Injections for Joint Pain Sales (Units) by Application (2025-2030)

Table 62. Global Corticosteroid Injections for Joint Pain Sales Market Share by Application (2019-2024)

Table 63. Global Corticosteroid Injections for Joint Pain Sales Market Share by Application (2025-2030)

Table 64. Global Corticosteroid Injections for Joint Pain Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Corticosteroid Injections for Joint Pain Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Application (2019-2024)

Table 67. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Application (2025-2030)

Table 68. Global Corticosteroid Injections for Joint Pain Price (USD/Unit) by Application (2019-2024)

Table 69. Global Corticosteroid Injections for Joint Pain Price (USD/Unit) by Application (2025-2030)

Table 70. Allergan Corporation Information

Table 71. Allergan Description and Business Overview

Table 72. Allergan Corticosteroid Injections for Joint Pain Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 73. Allergan Corticosteroid Injections for Joint Pain Product

Table 74. Allergan Recent Developments/Updates

Table 75. Pfizer Corporation Information

Table 76. Pfizer Description and Business Overview

Table 77. Pfizer Corticosteroid Injections for Joint Pain Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 78. Pfizer Corticosteroid Injections for Joint Pain Product

Table 79. Pfizer Recent Developments/Updates

Table 80. Sanofi Corporation Information

Table 81. Sanofi Description and Business Overview

Table 82. Sanofi Corticosteroid Injections for Joint Pain Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 83. Sanofi Corticosteroid Injections for Joint Pain Product

Table 84. Sanofi Recent Developments/Updates

Table 85. Anika Therapeutics Corporation Information

Table 86. Anika Therapeutics Description and Business Overview

Table 87. Anika Therapeutics Corticosteroid Injections for Joint Pain Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 88. Anika Therapeutics Corticosteroid Injections for Joint Pain Product

Table 89. Anika Therapeutics Recent Developments/Updates

Table 90. Ferring Corporation Information

Table 91. Ferring Description and Business Overview

Table 92. Ferring Corticosteroid Injections for Joint Pain Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 93. Ferring Corticosteroid Injections for Joint Pain Product

Table 94. Ferring Recent Developments/Updates

Table 95. Bioventus Corporation Information

Table 96. Bioventus Description and Business Overview

Table 97. Bioventus Corticosteroid Injections for Joint Pain Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 98. Bioventus Corticosteroid Injections for Joint Pain Product

Table 99. Bioventus Recent Developments/Updates

Table 100. Flexion Therapeutics Corporation Information

Table 101. Flexion Therapeutics Description and Business Overview

Table 102. Flexion Therapeutics Corticosteroid Injections for Joint Pain Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 103. Flexion Therapeutics Corticosteroid Injections for Joint Pain Product

Table 104. Flexion Therapeutics Recent Developments/Updates

Table 105. Zimmer Biomet Corporation Information

Table 106. Zimmer Biomet Description and Business Overview

Table 107. Zimmer Biomet Corticosteroid Injections for Joint Pain Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 108. Zimmer Biomet Corticosteroid Injections for Joint Pain Product

Table 109. Zimmer Biomet Recent Developments/Updates

Table 110. SEIKAGAKU Corporation Information

Table 111. SEIKAGAKU Description and Business Overview

Table 112. SEIKAGAKU Corticosteroid Injections for Joint Pain Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 113. SEIKAGAKU Corticosteroid Injections for Joint Pain Product

Table 114. SEIKAGAKU Recent Developments/Updates

Table 115. Chugai Pharma Corporation Information

Table 116. Chugai Pharma Description and Business Overview

Table 117. Chugai Pharma Corticosteroid Injections for Joint Pain Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 118. Chugai Pharma Corticosteroid Injections for Joint Pain Product

Table 119. Chugai Pharma Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Corticosteroid Injections for Joint Pain Distributors List

Table 123. Corticosteroid Injections for Joint Pain Customers List

Table 124. Corticosteroid Injections for Joint Pain Market Trends

Table 125. Corticosteroid Injections for Joint Pain Market Drivers

Table 126. Corticosteroid Injections for Joint Pain Market Challenges

Table 127. Corticosteroid Injections for Joint Pain Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Corticosteroid Injections for Joint Pain

Figure 2. Global Corticosteroid Injections for Joint Pain Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Corticosteroid Injections for Joint Pain Market Share by Type in 2023 & 2030

Figure 4. Knee & Ankle Product Picture

Figure 5. Hip Joint Product Picture

Figure 6. Shoulder & Elbow Product Picture

Figure 7. Facet Joints of the Spine Product Picture

Figure 8. Others Product Picture

Figure 9. Global Corticosteroid Injections for Joint Pain Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global Corticosteroid Injections for Joint Pain Market Share by Application in 2023 & 2030

Figure 11. Hospital Pharmacies

Figure 12. Retail Pharmacies

Figure 13. Online Pharmacies

Figure 14. Global Corticosteroid Injections for Joint Pain Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Corticosteroid Injections for Joint Pain Market Size (2019-2030) & (US$ Million)

Figure 16. Global Corticosteroid Injections for Joint Pain Sales (2019-2030) & (Units)

Figure 17. Global Corticosteroid Injections for Joint Pain Average Price (USD/Unit) & (2019-2030)

Figure 18. Corticosteroid Injections for Joint Pain Report Years Considered

Figure 19. Corticosteroid Injections for Joint Pain Sales Share by Manufacturers in 2023

Figure 20. Global Corticosteroid Injections for Joint Pain Revenue Share by Manufacturers in 2023

Figure 21. The Global 5 and 10 Largest Corticosteroid Injections for Joint Pain Players: Market Share by Revenue in 2023

Figure 22. Corticosteroid Injections for Joint Pain Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 23. Global Corticosteroid Injections for Joint Pain Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 24. North America Corticosteroid Injections for Joint Pain Sales Market Share by Country (2019-2030)

Figure 25. North America Corticosteroid Injections for Joint Pain Revenue Market Share by Country (2019-2030)

Figure 26. U.S. Corticosteroid Injections for Joint Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Canada Corticosteroid Injections for Joint Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. Europe Corticosteroid Injections for Joint Pain Sales Market Share by Country (2019-2030)

Figure 29. Europe Corticosteroid Injections for Joint Pain Revenue Market Share by Country (2019-2030)

Figure 30. Germany Corticosteroid Injections for Joint Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. France Corticosteroid Injections for Joint Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. U.K. Corticosteroid Injections for Joint Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Italy Corticosteroid Injections for Joint Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Russia Corticosteroid Injections for Joint Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Asia Pacific Corticosteroid Injections for Joint Pain Sales Market Share by Region (2019-2030)

Figure 36. Asia Pacific Corticosteroid Injections for Joint Pain Revenue Market Share by Region (2019-2030)

Figure 37. China Corticosteroid Injections for Joint Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Japan Corticosteroid Injections for Joint Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. South Korea Corticosteroid Injections for Joint Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. India Corticosteroid Injections for Joint Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Australia Corticosteroid Injections for Joint Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Taiwan Corticosteroid Injections for Joint Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Indonesia Corticosteroid Injections for Joint Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Thailand Corticosteroid Injections for Joint Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Malaysia Corticosteroid Injections for Joint Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Philippines Corticosteroid Injections for Joint Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Latin America Corticosteroid Injections for Joint Pain Sales Market Share by Country (2019-2030)

Figure 48. Latin America Corticosteroid Injections for Joint Pain Revenue Market Share by Country (2019-2030)

Figure 49. Mexico Corticosteroid Injections for Joint Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Brazil Corticosteroid Injections for Joint Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Argentina Corticosteroid Injections for Joint Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Middle East & Africa Corticosteroid Injections for Joint Pain Sales Market Share by Country (2019-2030)

Figure 53. Middle East & Africa Corticosteroid Injections for Joint Pain Revenue Market Share by Country (2019-2030)

Figure 54. Turkey Corticosteroid Injections for Joint Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Corticosteroid Injections for Joint Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. U.A.E Corticosteroid Injections for Joint Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. Global Sales Market Share of Corticosteroid Injections for Joint Pain by Type (2019-2030)

Figure 58. Global Revenue Market Share of Corticosteroid Injections for Joint Pain by Type (2019-2030)

Figure 59. Global Corticosteroid Injections for Joint Pain Price (USD/Unit) by Type (2019-2030)

Figure 60. Global Sales Market Share of Corticosteroid Injections for Joint Pain by Application (2019-2030)

Figure 61. Global Revenue Market Share of Corticosteroid Injections for Joint Pain by Application (2019-2030)

Figure 62. Global Corticosteroid Injections for Joint Pain Price (USD/Unit) by Application (2019-2030)

Figure 63. Corticosteroid Injections for Joint Pain Value Chain

Figure 64. Corticosteroid Injections for Joint Pain Production Process

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Distributors Profiles

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions